Never adjust your dosing schedule without clinical advice, as this can worsen side effects or disrupt treatment
However, definitive evidence from adequately powered human trials demonstrating cognitive benefits is still lacking, and ongoing phase 3 studies are investigating these potential effects
Do they have a standard protocol for reducing doses before discontinuation
The key rheumatology question, however, is why some people with conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis are reporting symptom improvements while taking them
To view a copy of this licence, visit About this article Cite this article Trebulov, K., Klementov, K., Bednakov, S